Article thumbnail

High-density lipoprotein proteome dynamics in human endotoxemia

By Johannes HM Levels, Pierre Geurts, Helen Karlsson, Raphaël Marée, Stefan Ljunggren, Louise Fornander, Louis Wehenkel, Mats Lindahl, Erik SG Stroes, Jan A Kuivenhoven and Joost CM Meijers
Topics: Research
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2009). A: Proteomic Analysis of Defined HDL Subpopulations Reveals ParticleSpecific Protein Clusters. Relevance to Antioxidative Function. Arterioscler Thromb Vasc Biol
  2. (2011). A: Serum Amyloid A Facilitates the Binding of High-Density Lipoprotein From Mice Injected With Lipopolysaccharide to Vascular Proteoglycans. Arterioscler Thromb Vasc Biol
  3. (1996). Aebersold R: Characterization of human serum amyloid A protein isoforms separated by two-dimensional electrophoresis by liquid chromatography/ electrospray ionization tandem mass spectrometry. Electrophoresis
  4. (2002). Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime.
  5. (2000). Atherosclerosis. Nature
  6. (2007). Bots ML: Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia.
  7. (2009). Camejo G: Proteomics of Apolipoproteins and Associated Proteins From Plasma High-Density Lipoproteins. Arterioscler Thromb Vasc Biol
  8. (2008). Combined statin and niacin therapy remodels the high-density lipoprotein proteome. Circulation
  9. (2004). Getz GS: Influence of apoA-I and apoE on the formation of serum amyloid Acontaining lipoproteins in vivo and in vitro.
  10. (2004). Grunfeld C: Effects of infection and inflammation on lipid and lipoprotein metabolism: Mechanisms and consequences to the host.
  11. (2005). Haeberli A: Mass spectrometry-based analytical tools for the molecular protein characterization of human plasma lipoproteins. Proteomics
  12. (2007). Heinecke JW: Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL.
  13. (2000). Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions: PON1 esterase and peroxidase-like activities. Circulation
  14. (2010). JA: The HDL hypothesis - Does high-density lipoprotein protect from atherosclerosis? J Lipid Res
  15. (2005). Lipoproteomics II: mapping of proteins in high-density lipoprotein using two-dimensional gel electrophoresis and mass spectrometry. Proteomics
  16. (2003). Low paraoxonase activity predicts coronary events in the Caerphilly Prospective Study. Circulation
  17. (2006). Meijers JC: Proteomic analysis of high-density lipoprotein. Proteomics
  18. (2008). Monomeric calgranulins measured by SELDI-TOF mass spectrometry and calprotectin measured by ELISA as biomarkers in arthritis. Clin Chem
  19. (2009). ND: Impaired antioxidant activity of high-density lipoprotein in chronic kidney disease. Transl Res
  20. (2003). RW: Detection of novel truncated forms of human serum amyloid A protein in human plasma.
  21. (2002). Shouldering the risk factor burden: infection, atherosclerosis, and the vascular endothelium. Circulation
  22. (2009). Stalenhoef AF: Anti-inflammatory therapy with tumour necrosis factor alpha inhibitors improves highdensity lipoprotein cholesterol antioxidative capacity in rheumatoid arthritis patients. Ann Rheum Dis
  23. (2005). Wehenkel L: Proteomic mass spectra classification using decision tree based ensemble methods. Bioinformatics